Show simple item record

dc.contributor.authorVenkatachalam, G.
dc.contributor.authorKumar, Alan Prem
dc.contributor.authorSakharkar, K.
dc.contributor.authorThangavel, S.
dc.contributor.authorClement, M.
dc.contributor.authorSakharkar, M.
dc.date.accessioned2017-03-15T22:17:42Z
dc.date.available2017-03-15T22:17:42Z
dc.date.created2017-02-26T19:31:41Z
dc.date.issued2011
dc.identifier.citationVenkatachalam, G. and Kumar, A.P. and Sakharkar, K. and Thangavel, S. and Clement, M. and Sakharkar, M. 2011. PPARγ disease gene network and identification of therapeutic targets for prostate cancer. Journal of Drug Targeting. 19 (9): pp. 781-796.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/50187
dc.identifier.doi10.3109/1061186X.2011.568062
dc.description.abstract

Peroxisome proliferator-activated receptor (PPAR) belongs to the nuclear hormone receptor superfamily. Recently published reports demonstrate the importance of a direct repeat 2 (DR2) as a PPARγ-responsive element in addition to the canonical direct repeat 1 (DR1) Peroxisome proliferator response elements (PPREs). However, a comprehensive and systematic approach to constructing de novo disease-specific gene networks for PPARγ is lacking, especially one that includes PPARγ target genes containing either DR1 or DR2 site within their promoter region. Here, we computationally identified 1154 PPARγ direct target genes and constructed the PPARγ disease gene network, which revealed 138 PPARγ target genes that are associated with 65 unique diseases. The network shows that PPARγ target genes are highly associated with cancer and neurological diseases. Thirty-eight PPARγ direct target genes were found to be involved in prostate cancer and two key (hub) PPARγ direct target genes, PRKCZ and PGK1, were experimentally validated to be repressed upon PPARγ activation by its natural ligand, 15d-PGJ2 in three prostate cancer cell lines. We proposed that PRKCZ and PGK1 could be novel therapeutic targets for prostate cancer. These investigations would not only aid in understanding the molecular mechanisms by which PPARγ regulates disease targets but would also lead to the identification of novel PPARγ gene targets.

dc.publisherinforma UK Ltd
dc.titlePPARγ disease gene network and identification of therapeutic targets for prostate cancer
dc.typeJournal Article
dcterms.source.volume19
dcterms.source.number9
dcterms.source.startPage781
dcterms.source.endPage796
dcterms.source.issn1061-186X
dcterms.source.titleJournal of Drug Targeting
curtin.departmentSchool of Biomedical Sciences
curtin.accessStatusFulltext not available


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record